USPTO 2015–2025 USPTO PatentsView US Corporation

Endra Life Sciences Inc.

USPTO PatentsView assignee record - 38 granted patents across 16 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Endra ranks #8,378 of 49,997 tracked US assignees by granted-patent volume, with 38 patents across 16 technology areas.

#8,378
of 49,997 US assignees by volume
Top 36%
by Innovation Score (40.4/100)
12.9
avg claims per patent
+417%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8378 · US Corporation #8,378 · 38 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 38 grants
  • UPPER-Q #8,378/49,997
  • PHOTO-FINISH Diehl Metering Systems
  • CPC-FOCUS A61B · 16 areas
  • INNOV-PAR 40.4/100
  • CLAIMS-RICH 12.9 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +417% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Diehl Metering Systems GmbH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Endra’s 40.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Endra

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Endra's Innovation Score is 40.4/100 (top 36% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Endra?

Each dot is one of Endra’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Endra’s own 12.9 claims/patent is at or below the 16.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Endra vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 37.938.038.03838.038.038.1 1015202530 Granted patents (volume) Avg claims / patent Diehl Metering Systems GmbH - 38, 20.68Diehl Metering Sy…Duke Manufacturing Co. - 38, 24.55Duke ManufacturingDunAn Microstaq, Inc. - 38, 13.39Dunan MicrostaqEBI, LLC - 38, 16.05EBIElement Six (UK) Limited - 38, 14.53Element Six (UK)Elkem Silicones France SAS - 38, 17.89Elkem Silicones F…Emirates Telecommunications Corporation - 38, 19Emirates Telecomm…Endocyte, Inc. - 38, 15.11EndocyteEndra Life Sciences Inc. - 38, 12.89Endra Life Scienc…
Endra vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Endra's grants concentrate

Endra Life Sciences Inc. is a focused PatentsView assignee: 16 CPC subclasses with 76.3% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2021 (11 grants) versus a trough of 1 in 2019. By volume, Endra sits between Diehl Metering Systems GmbH and Endocyte, Inc..

Endra's three-year grant acceleration

Endra Life Sciences Inc. shows 15 grants in 2022–2024 against only 17 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Endra's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Endra holds 38 patents at rank #8,374, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Endra

By rank, the assignees closest to #8,374 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Endra's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Endra, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Endra ranks #643 of 7,127 assignees by patent count in that subclass.

Endra's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 36% higher than 64% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

051015 2018201920202021202220232025 1
USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table
Endra Life Sciences Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2018 5 13.2%
2019 1 2.6%
2020 5 13.2%
2021 11 28.9%
2022 10 26.3%
2023 5 13.2%
2025partial year 1 2.6%

Which technologies does Endra Life Sciences Inc. patent most?

Top 15 of 16 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Endra Life Sciences Inc.'s patent record in context - here's where to go next.

  • Endra Life Sciences Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 76.3% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #8,378 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Endra Life Sciences Inc. against Diehl Metering Systems GmbH, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 40.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.